These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 14575972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.
    Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT.
    Diabet Med; 2000 Jul; 17(7):543-5. PubMed ID: 10972586
    [Abstract] [Full Text] [Related]

  • 3. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Froguel P, Hattersley AT.
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [Abstract] [Full Text] [Related]

  • 4. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.
    Pearson ER, Badman MK, Lockwood CR, Clark PM, Ellard S, Bingham C, Hattersley AT.
    Diabetes Care; 2004 May; 27(5):1102-7. PubMed ID: 15111528
    [Abstract] [Full Text] [Related]

  • 5. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC, Sun J, Scroggin E, Teng K, Hasstedt SJ.
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
    Boileau P, Wolfrum C, Shih DQ, Yang TA, Wolkoff AW, Stoffel M.
    Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
    [Abstract] [Full Text] [Related]

  • 8. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
    Hansen T, Eiberg H, Rouard M, Vaxillaire M, Møller AM, Rasmussen SK, Fridberg M, Urhammer SA, Holst JJ, Almind K, Echwald SM, Hansen L, Bell GI, Pedersen O.
    Diabetes; 1997 Apr; 46(4):726-30. PubMed ID: 9075819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.
    Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS.
    J Clin Invest; 1998 May 15; 101(10):2215-22. PubMed ID: 9593777
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
    Betteridge DJ, Vergès B.
    Diabetologia; 2005 Dec 15; 48(12):2477-81. PubMed ID: 16283239
    [Abstract] [Full Text] [Related]

  • 13. Different genes, different diabetes: lessons from maturity-onset diabetes of the young.
    Stride A, Hattersley AT.
    Ann Med; 2002 Dec 15; 34(3):207-16. PubMed ID: 12173691
    [Abstract] [Full Text] [Related]

  • 14. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S, Castiglione A, Ghigo E, Gentile L, Durazzo M, Cavallo-Perin P, Ciccone G.
    Eur J Endocrinol; 2013 Jul 15; 169(1):117-26. PubMed ID: 23660643
    [Abstract] [Full Text] [Related]

  • 15. Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients.
    Feng Y, Mao G, Ren X, Xing H, Tang G, Li Q, Li X, Sun L, Yang J, Ma W, Wang X, Xu X.
    Diabetes Care; 2008 Oct 15; 31(10):1939-44. PubMed ID: 18599530
    [Abstract] [Full Text] [Related]

  • 16. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers.
    Stride A, Ellard S, Clark P, Shakespeare L, Salzmann M, Shepherd M, Hattersley AT.
    Diabetes Care; 2005 Jul 15; 28(7):1751-6. PubMed ID: 15983330
    [Abstract] [Full Text] [Related]

  • 17. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
    Menzel R, Kaisaki PJ, Rjasanowski I, Heinke P, Kerner W, Menzel S.
    Diabet Med; 1998 Oct 15; 15(10):816-20. PubMed ID: 9796880
    [Abstract] [Full Text] [Related]

  • 18. Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization.
    Yoshiuchi I, Yamagata K, Yang Q, Iwahashi H, Okita K, Yamamoto K, Oue T, Imagawa A, Hamaguchi T, Yamasaki T, Horikawa Y, Satoh T, Nakajima H, Miyazaki J, Higashiyama S, Miyagawa J, Namba M, Hanafusa T, Matsuzawa Y.
    Diabetologia; 1999 May 15; 42(5):621-6. PubMed ID: 10333057
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
    Surmely JF, Guenat E, Philippe J, Dussoix P, Schneiter P, Temler E, Vaxillaire M, Froguel P, Jéquier E, Tappy L.
    Diabetes; 1998 Sep 15; 47(9):1459-63. PubMed ID: 9726235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.